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Available online 24 January 2017Background:Non-front-fanged colubroid snakes comprise about two-thirds of extant ophidian species. Themed-
ical signiﬁcance of themajority of these snakes is unknown, but at least ﬁve species have caused life-threatening
or fatal human envenomings. However, the venoms of only a small number of species have been explored.
Methods: A combined venomic and venom gland transcriptomic approach was employed to characterise of
venom of Dispholidus typus (boomslang), the snake that caused the tragic death of Professor Karl Patterson
Schmidt. The ability of CroFab™ antivenom to immunocapture boomslang venom proteins was investigated
using antivenomics.
Results: Transcriptomic-assisted proteomic analysis identiﬁed venom proteins belonging to seven protein fami-
lies: three-ﬁnger toxin (3FTx); phospholipase A2 (PLA2); cysteine-rich secretory proteins (CRISP); snake
venom (SV) serine proteinase (SP); C-type lectin-like (CTL); SV metalloproteinases (SVMPs); and disintegrin-
like/cysteine-rich (DC) proteolytic fragments. CroFab™ antivenom efﬁciently immunodepleted some boomslang
SVMPs.
Conclusions: The present work is the ﬁrst to address the overall proteomic proﬁle of D. typus venom. This study
allowed us to correlate the toxin composition with the toxic activities of the venom. The antivenomic analysis
suggested that the antivenom available at the time of the unfortunate accident could have exhibited at least
some immunoreactivity against the boomslang SVMPs responsible for the disseminated intravascular coagula-
tion syndrome that caused K.P. Schmidt's fatal outcome.
General signiﬁcance: This study may stimulate further research on other non-front-fanged colubroid snake
venoms capable of causing life-threatening envenomings to humans, which in turn should contribute to prevent
fatal human accidents, such as that unfortunately suffered by K.P. Schmidt.
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Karl Patterson Schmidt (June 19, 1890, Lake Forest, Illinois–Septem-
ber 26, 1957, Chicago) was an eminent American herpetologist at the
Field Museum in Chicago, where he was zoological curator from 1941
to 1955, and a leading expert on coral snakes. He died nearly 6 decades
ago of internal bleeding from his eyes, lungs, kidneys, heart, and brainnom Research Unit, Liverpool
5QA, United Kingdom.
ómica Estructural y Funcional,
1, 46010, Valencia, Spain.
. Casewell), jcalvete@ibv.csic.es
B.V. This is an open access article u24 h after being bitten on his thumb by a juvenile South African green
tree snake, also known as the boomslang [1]. The snake had been sent
to him for identiﬁcation by the then director of the Lincoln Park Zoo
(Chicago. IL), Richard Marlin Perkins [2].
Despite studies by Grasset et al. (1940) [3] having shown marked
procoagulant activity associated with D. typus envenomation in vivo,
and serious human envenomations by boomslangs having been docu-
mented [4–6], K. P. Schmidt, along with many of his contemporary her-
petologists, wrongly believed that rear-fanged colubroid snakes could
not produce a fatal venom dose for humans. With this conviction, and
guided by his scientiﬁc curiosity, following the bite hemademeticulous
notes about the effects he experienced as the venom took hold of his
body. Schmidt was asked just a few hours before he died if he wanted
medical care, but he refused because it would upset the symptoms hender the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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released the video “Diary of a snakebite death” (https://www.youtube.
com/watch?v=jEyjF2bNQOA) detailing, in his own words and using
his notes, the last hours of Schmidt's life. We have here used the pub-
lished facts of this tragic event to emphasise the important contribu-
tions that modern biological science can make to clinical medicine,
and have not used any personal material or data in our analyses.
The boomslang, Dispholidus typus (Smith, 1828) [7], “tree snake” in
Afrikaans andDutch, is a sub-SaharanAfrican indigenous specieswidely
distributed throughout much of the central and southern regions of the
continent, including Swaziland, Botswana, Namibia, Mozambique, and
Zimbabwe, but has been observed as far north as Nigeria and southern
Chad, and as far east as Kenya [8,9; http://reptile-database.reptarium.
cz]. Boomslangs are a large (average adult total length is 100–160 cm,
but some exceed 183 cm), diurnal and almost exclusively arboreal
opisthoglyphous (rear-fanged) colubroid snake species (Colubridae:
Colubrinae). Boomslangs feed on chameleons and other arboreal lizards,
frogs, and occasionally small mammals, birds, and eggs from nesting
birds [8–10]. The boomslang is a mellow, shy snake that will ﬂee from
anything too large to eat, and will bite only when people attempt to
handle, catch or kill the animal [8–10].
Today, the boomslang is considered one of the most deadly African
snakes, and is probably responsible for more serious bites in humans
than any other non-front-fanged colubroid species. Boomslangs have
very long fangs and can open their mouths a full 180 degrees to bite.
An adult boomslang has 1.6–8 mg of venom, whose median lethal
dose (LD50) in mice is 0.07–0.1 mg/kg (i.v.), 12.5 mg/kg (s.c.), and
1.3–1.8 mg/kg (i.p.) [11–13]. Typical symptoms associated with
envenomings by D. typus include disseminated intravascular coagula-
tion (DIC)-like syndrome (also referred to as venom induced consump-
tion coagulopathy) with delayed onset of spontaneous haemorrhage
into tissues [9,10,14–17]. Renal failure may also result from acute tubu-
lar necrosis caused by pigment nephropathy. DIC is caused by the con-
sumption of ﬁbrinogen (deﬁbrination) into many small clots, resulting
in blood that loses the ability to clot and thus the victim bleeds to
death. An indication of the important health issues associated with D.
typus is that its venom is the only colubroid snake against which the
South African Vaccine Producers manufactures a commercial monova-
lent antivenom [18].
Despite comprising approximately two-thirds of the described spe-
cies of advanced snakes, venoms of non-front-fanged colubroid snakes
have not been extensively investigated. Modest information on the
composition of boomslang venom is available. Gel-based assays demon-
strated the presence of phospholipase A2 (PLA2) [19,20], caseinolytic
[21] and gelatinase [7] activities. A 65 kDa snake venommetalloprotein-
ase (SVMP) bearing antigenic determinants recognised byWestern blot
by polyclonal antibodies raised against the haemorrhagic PIII-SVMP
jararhagin (isolated from the venomof the Brazilian pitviper B. jararaca)
was also demonstrated to be present in boomslang venom [22]. Proteins
consistent with the masses and retention times of three-ﬁnger toxins
(3FTxs) (7–8 kDa), PLA2 (13–14 kDa) and cysteine-rich secretory pro-
teins (CRISP) (25 kDa) have been identiﬁed in a number of non-front-
fanged colubroid venoms, including D. typus, by liquid chromatography
andmass spectrometry [23]. However, venoms act as integrated pheno-
types, and a detailed view of the venom proteome of this medically im-
portant snake remains lacking. Here, we have applied a combined snake
venomics and venom gland transcriptomic approach [24] to ﬁll this
knowledge gap.
2. Materials and methods
2.1. Venom and venom gland
Lyophilised venom from specimens of D. typus of South African ori-
gin was obtained from Latoxan, France and stored at 4 °C until use.
The venom gland was dissected from a single euthanised specimen ofD. typus of Tanzanian origin that was maintained in the herpetarium
of the Liverpool School of Tropical Medicine, UK. Dissected venom
glands were immediately ﬂash frozen in liquid nitrogen and stored
cryogenically until use.2.2. Characterisation of the venom gland transcriptome
We generated a venom gland transcriptome in a similar manner to
those previously described by our group [25,26]. The venom gland
was ﬁrst homogenised under liquid nitrogen using a pestle and mortar
and then subsequently by using a TissueRuptor (Qiagen), before total
RNAwas extracted using the TRIzol Plus RNA Puriﬁcation kit (Life Tech-
nologies, Carlsbad, CA, USA). The RNA sample was then DNAse treated
(On-Column PureLink DNase, Life Technologies) and 1 μg of the
resulting RNA enriched using a polyA selection method (Dynabeads
mRNA Puriﬁcation Kit from total RNA preps, ThermoFisher Scientiﬁc).
The RNA-Seq library was prepared from 50 ng of the enriched RNAma-
terial using the TruSeq Stranded mRNA HT Sample Prep Kit (Illumina).
During the preparation, dual index adapters were used so that other
RNA samples in the sequencing pool (not described here) had a unique
index at both the 5′ and 3′ ends. The sequencing library was ampliﬁed
with 12 cycles PCR and then puriﬁed using AMPure XP beads
(Agencourt, Brea, CA, USA), quantiﬁed using the Qubit dsDNA HS
Assay Kit (Life Technologies) and the size distribution assessed using a
Bioanalyser (Agilent). The quantity and quality of the resulting sample
was also assessed by qPCR using the Illumina Library Quantiﬁcation
Kit on a Roche Light Cycler LC480II according tomanufacturer's instruc-
tions. Finally, the template DNA was denatured according to the proto-
col described in the Illumina cBot User guide and loaded at 10 pM
concentration. Sequencing was carried out on a single lane of an
IlluminaMiSeq with 2 × 250 bp paired-end sequencing and v2 chemis-
try (Centre for Genomic Research, University of Liverpool, UK).
The ensuing read data was quality processed, ﬁrst by removing the
presence of any adapter sequences using Cutadapt (https://
code.google.com/p/cutadapt/) and then by trimming low quality bases
using Sickle (https://github.com/najoshi/sickle). Reads were trimmed
if bases at the 3′ end matched the adapter sequence for 3 bp or more,
and further trimmed with a minimum window quality score of 20.
After trimming, reads shorter than 10 bp were removed. Processed
paired-end read data were next assembled into contigs using the de
novo transcriptome assembler VTBuilder [27] executedwith the follow-
ing parameters: min. transcript length 150 bp;min. read length 150 bp;
min. isoform similarity 96%. The isoform similarity parameter is a stan-
dard parameter optimised to discriminate between isoforms excepting
minor polymorphisms in mixed specimen samples and sequencing er-
rors. Raising this to close to 100% could potentially return a small num-
ber of transcripts between 96 and 100% identity that have beenmerged
during the assembly process but can be detrimental to the quality (both
length and representation) of the ﬁnal assembly due to the effects of
under-clustering driven by sequencing or other minor polymorphic
variations.
Assembled contigs were annotated with BLAST2GO Pro v3 [28,29]
using the BLASTX algorithm with a signiﬁcance threshold of 1e−3, to
provide BLAST annotations against NCBI's non redundant (NR) protein
database release 67 followed by mapping to gene ontology terms, and
Interpro domain annotation using default parameters. Contigs were
then translated using CLC Genomics Workbench 5 (CLC bio, Aarhus,
Denmark) to provide a six reading frame sequence database for the pro-
teomic characterisation of venom components. In addition, contigs an-
notated as toxins were also analysed manually to aid proteomic
identiﬁcations, with their correct open reading frames identiﬁed via se-
quence alignments with known toxin sequences identiﬁed via BLAST.
Trimmed raw sequencing reads have been deposited in the SRA data-
base of NCBI (http://www.ncbi.nlm.nih.gov/sra) with the BioProject
identiﬁer PRJNA347284. Assembled contigs can be found in
816 D. Pla et al. / Biochimica et Biophysica Acta 1861 (2017) 814–823Supplementary File 1 and BLAST2GOannotationﬁles are available by re-
quest from the corresponding author.
2.3. Phylogenetic analysis of snake venom metalloproteinases
We reconstructed the evolutionary history of the SVMP gene family
using Bayesian inference. Boomslang SVMP contigs exhibiting sequence
data that encoded the characteristic ‘H-box’motif of themetalloprotein-
ase domain were aligned with representative SVMPs isolated from
other snakes that were used in previous evolutionary studies [30,31].
We used the MUSCLE algorithm [32] in MEGA v7 [33] to align the se-
quences in amino acid space, and we selected the most closely related
ADAM (a disintegrin and metalloproteinase) gene, ADAM28 [34] from
Homo sapiens (GenBank: NP_055080) as our outgroup sequence. Our
ﬁnal dataset consisted of 55 sequences and 570 amino acid positions.
We next determined the optimisedmodel of sequence evolution chosen
by the Akaike Information Criterion in MEGA v7 [33] and implemented
this (WAG + G) in MrBayes v3.2.3 [35]. Bayesian inference analyses
were performedusing four simultaneous runswith four different chains
(three hot, one cold) for 10× 106 generations and sampling every 500th
cycle from the chain and using default settings in regards to priors. Trac-
er v1.4 [36] was used to estimate effective samples sizes for all parame-
ters (conﬁrmed as N200), and to construct plots of ln(L) against
generation to verify the point of convergence (burnin); trees generated
prior to this point (before 2 × 106 generations) were discarded and a
consensus tree constructed from those remaining.
2.4. Venomic analysis: isolation and proteomic characterization of the ven-
om proteins
0.75 mg of crude, lyophilised venom was dissolved in 200 μL of 5%
acetonitrile in MilliQ® (Millipore Co.) water containing 0.1%
triﬂuoroacetic acid (TFA), centrifuged to remove debris, and separated
by reverse-phase (RP) HPLC using a Teknokroma Europa Protein 300
C18 (0.4 cm × 25 cm, 5 μm particle size, 300 Å pore size) column and
an LC 1100 High Pressure Gradient System (Agilent Technologies,
Santa Clara, CA, USA) equipped with DAD detector and micro-Auto-
sampler [37]. Theﬂow ratewas set to 1mL/min and the columnwas de-
velopedwith a linear gradient of 0.1% TFA inwater (solution A) and ace-
tonitrile (solution B) using the following column elution conditions:
isocratically (5% B) for 5 min, followed by 5%–25% B for 10 min, 25%–
45% B for 60min, and 45%–70% for 10min. Protein detectionwas carried
out at 215 nm with a reference wavelength of 400 nm. Fractions were
collected manually, dried in a vacuum centrifuge (Savant), and
redissolved in water, and submitted to molecular mass determination
using a SYNAPT® G2 High Deﬁnition Mass Spectrometry System (Wa-
ters Corp., Milford, MA, USA), and SDS-PAGE analysis in 15% polyacryl-
amide gels, under reducing and non-reducing conditions. Gels were
stained with Coomassie Brilliant Blue R-250 (Sigma-Aldrich, St. Louis,
MO, USA).
Electrophoretic protein bands were excised from a Coomassie Bril-
liant Blue-stained SDS-PAGE gel and subjected to in-gel reduction
(10 mM dithiothreitol) and alkylation (50 mM iodoacetamide), follow-
ed by overnight sequencing-grade trypsin digestion (66 ng/μL in 25mM
ammonium bicarbonate, 10% acetonitrile; 0.25 μg/sample) in an auto-
mated processor (ProGest Protein Digestion Workstation, Genomic So-
lution Ltd., Cambridgeshire, UK) following the manufacturer's
instructions. Tryptic digests were dried in a SpeedVac (Savant™, Ther-
mo Scientiﬁc Inc., West Palm Beach, FL, USA), redissolved in 15 μL of
0.1% formic acid inwater, and submitted to LC-MS/MS. To this end, tryp-
tic peptides were separated by nano-Acquity UltraPerformance LC®
(UPLC®, Waters Corporation, Milford, MA, USA) using BEH130 C18
(100 μm × 100 mm, 1.7 μm particle size) column in-line with a
SYNAPT® G2 High Deﬁnition Mass Spectrometry System (Waters).
The ﬂow rate was set to 0.6 μL/min and the column was developed
with a linear gradient of 0.1% formic acid in water (solution A) and0.1% formic acid in acetonitrile (solution B), isocratically 1% B for
1 min, followed by 1%–12% B for 1 min, 12%–40% B for 15 min, 40%–
85% B for 2 min. Doubly- and triply-charged ions were selected for col-
lision-induced dissociation (CID) MS/MS. Fragmentation spectra were
interpreted (a) manually (de novo sequencing); (b) using the on-line
formof theMASCOT programat http://www.matrixscience.com against
NCBInr database, a comprehensive, non-identical protein database
compiled from GenBank CDS translations, PIR, SwissProt, PRF, and
PDB; and (c) processed in Waters Corporation's ProteinLynx Global
(PLG) SERVER 2013 version 2.5.2. (with Expression version 2.0) and
the generated .pkl peak list ﬁles searched against the D. typus
transcriptomic dataset described in this paper. MS/MS mass tolerance
was set to ±0.6 Da. Carbamidomethyl cysteine and oxidation of methi-
onine were selected as ﬁxed and variable modiﬁcations, respectively.
The cut-off forMASCOT reportingwas set to the top 10 hits and allMAS-
COT identiﬁcations were manually veriﬁed. Amino acid sequence simi-
larity searches were performed against the NCBInr and UniProtKB
databases using the BLASTP program implemented in the WU-BLAST2
search engine at http://www.bork.embl-heidelberg.de.
The relative abundances (expressed as percentage of the total
venom proteins) of the different protein families were calculated as
the ratio of the sum of the areas of the reverse-phase chromatographic
peaks containing proteins from the same family to the total area of
venom protein peaks in the reverse-phase chromatogram [38,39].
When more than one protein band were present in a reverse-phase
HPLC fraction, their proportions were estimated by densitometry of
Coomassie-stained SDS-polyacrylamide gels using ImageJ version 1.47
(Free Software Foundation, Boston, MA, USA) (http://rsbweb.nih.gov/
ij). Conversely, the relative abundances of different proteins contained
in the sameSDS-PAGE bandwere estimated based on the relative ion in-
tensities of the three most abundant peptide ions associated with each
protein by MS/MS analysis. Finally, protein family abundances were es-
timated as the percentages of the total venom proteome.
2.5. Antivenomics
A second-generation antivenomics approach [40] was applied to ex-
amine the paraspeciﬁc immunoreactivity of CroFab™ (BTG Internation-
al Inc., West Conshohocken, PA, USA) antivenom against Dispholidus
typus venom. CroFab™ is a preparation of ovine Fab (monovalent) im-
munoglobulin fragments obtained from the blood of healthy sheep im-
munized with the following North American snake venoms: Crotalus
atrox (Western diamondback rattlesnake), C. adamanteus (Eastern dia-
mondback rattlesnake), C. scutulatus type A (Mojave rattlesnake) and
Agkistrodon piscivorus (Cottonmouth or Water Moccasin). The ﬁnal an-
tivenom product is prepared by fractionating the immunoglobulin
from the ovine serum, digesting it with papain, and isolating the
venom-speciﬁc Fab fragments on ion exchange and afﬁnity chromatog-
raphy columns. To prepare the antivenom afﬁnity column, 300 μL of
(CNBr-activated Sepharose™ 4B matrix from GE Healthcare) matrix
was packed in a Pierce centrifuge column and washed with 10 matrix
volumes of cold 1 mM HCl followed by two matrix volumes of 0.2 M
NaHCO3, 0.5MNaCl, pH8.3 (coupling buffer) to adjust the pH of the col-
umn to 7.0–8.0. Antivenom was dialysed against MilliQ® water,
lyophilised, and reconstituted in coupling buffer. The concentration of
the antivenom stock solution was determined spectrophotometrically
using an extinction coefﬁcient of 1.36 for a 1 mg/mL concentration of
Fab at 280 nm using a 1 cm light pathlength cuvette. 5.3 mg of polyva-
lent antivenomwere dissolved in a half matrix volume of coupling buff-
er and incubated with the matrix for 4 h at room temperature.
Antivenom coupling yield, estimated measuring A280 before and after
coupling of the antivenom and using the Beer-Lambert Law, was
5.1 mg. After the coupling, any remaining active groups were blocked
with 300 μL of 0.1 M Tris–HCl, pH 8.5 at room temperature for 4 h.
The column was alternately washed with three 300 μL volumes of
0.1 M acetate containing 0.5 M NaCl, pH 4.0–5.0, and three 300 μL
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then equilibrated with 5 volumes of working buffer solution (20 mM
phosphate buffer, 135 mM NaCl, pH 7.4; PBS). For the immunoafﬁnity
assay, increasing amounts (50 μg, 75 μg and 100 μg) of D. typus venom
were dissolved in half matrix volumes of PBS and incubatedwith the af-
ﬁnity matrix for 1 h at room temperature using an orbital shaker. As a
speciﬁcity control, 300 μL of CNBr-activated SepharoseTM 4B matrix
was incubated with venom and the control column was developed in
parallel to the immunoafﬁnity experiment. Non-retained fractions
were collected with 5 matrix volumes of PBS, and the immunocaptured
proteinswere elutedwith 5matrix volumes of elution buffer (0.1Mgly-
cine-HCl, pH 2.0) and neutralised with 150 μL 1 M Tris–HCl, pH 9.0. The
non-retained and the immunocaptured venom fractions were lyophi-
lized, reconstituted in 40 μL of MilliQ® water, and fractionated by re-
verse-phase HPLC using a Discovery® BIO Wide Pore C18
(15 cm × 2.1 mm, 3 μm particle size, 300 Å pore size) column using an
Agilent LC 1100 High Pressure Gradient System equipped with a DAD
detector. The column was developed at a ﬂow rate of 0.4 mL/min and
proteins eluted with a linear gradient of 0.1% TFA in MilliQ® water (so-
lution A) and 0.1% TFA in acetonitrile (solution B): isocratic at 5% solu-
tion B for 1 min, followed by 5–25% solution B for 5 min, 25–45%
solution B for 35 min, and 45–70% solution B for 5 min. Protein was de-
tected at 215 nm with a reference wavelength of 400 nm.
3. Results and discussion
We ﬁrst used a transcriptomic approach to characterise the toxin
genes expressed in the venom gland of D. typus, thus representing the
lethal arsenal that produced the proteins ultimately responsible for
the death of Prof. K.P. Schmidt. We next applied proteomic analysis to
uncover the venom's weaponry, and the integration of these two data
types allowed us to correlate the symptoms experienced by the
envenomed herpetologist with the composition of the lethal venom
employed by D. typus.
3.1. Transcriptome proﬁle of the D. typus venom gland
The boomslang venomgland transcriptome resulted in the assembly
of ~7.7 million paired-end reads into 3849 contigs with an average
length of 673 bp (300–7199 bp). Annotation of these putative genes re-
vealed 44 contigs that exhibited similarity with previously described
snake venom toxin types, particularly to those reported as major or
minor venom components in the venoms or the venom glands of non-
front-fanged snakes from the subfamilies Colubrinae, Dipsadinae, and
Natricinae [41,42]. Combined, these transcripts accounted for 36.26%
of the total gene expression identiﬁed in the venom gland (Fig. 1A). A
total of 2860 contigs were found to encode for non-toxin-relatedFig. 1. Summary statistics for the venom gland transcriptome of D. typus. Panel A) The relativ
detected in the venom gland. Panel B) A breakdown of the relative expression of toxin enc
phospholipase A2; CRISP, cysteine-rich secretory protein; SVSP, snake venom serine proteinas
factor; WAP, waprin; PIII-SVMP, snake venom metalloproteinase of class PIII.genes (50.25% of expression) and 943 contigs had no annotation
match (13.49%) (Fig. 1A).
Of the toxin types identiﬁed in the venom gland the snake venom
metalloproteinases were by far the most abundant in terms of both
contig numbers (26) and expression level (74.64% of all toxin-encoding
genes) (Fig. 1B). However, many of these contigs were partial in length
and non-overlapping, therefore this total contig number is likely to be
an overestimation of the number of SVMP genes actually expressed in
the D. typus venom gland. All of the SVMP contigs we identiﬁed were
members of the P-III class, which is unsurprising considering that P-II
and P-I SVMPs have only previously been detected from viperid snakes
[43,44]. It is worth noting that we did not ﬁnd any evidence of any atyp-
ical truncated SVMPs such as those previously described from the non-
front-fanged snake Psammophis mossambicus (family Lamprophiidae)
[45]. Phylogenetic analysis of boomslang SVMPs with representative
orthologs from other taxa revealed that all but one of the boomslang
SVMPs group together in a clade sister to that containing SVMPs from
the xenodontid snake Philodryas olfersii, the atractaspid Atractaspis
microlepidotus and various elapid snakes (Fig. 2). Interestingly, one of
the boomslang SVMPs (contig 0059) appears to be extremely basal,
and groups with an SVMP recovered from Naja atra at the very base of
the toxin radiation (Fig. 2). This data suggests that SVMP-encoding
genes may have duplicated prior to the divergence of viperid snakes
from the remaining caenophidians, although the low-level expression
of this gene in the boomslang, in comparison with the others, suggests
that it may be of lesser importance regarding its contribution to
boomslang venom toxicity.
The remaining toxin genes identiﬁed in the transcriptome were mem-
bers of the 3FTx, PLA2, CRISP, snake venom serine protease (SVSP), C-type
lectin (CTL), Kunitz-type protease inhibitor (KUN), vascular endothelial
growth factor (VEGF) and waprin (WAP) toxin families (Fig. 1B). Of
these, only the 3FTx, PLA2, CRISP and SVSP toxin families exhibited expres-
sion levels of N1% of the toxin-encoding genes identiﬁed in the tran-
scriptome. We found four contigs annotated as 3FTx, two of which were
lowly expressed and matched 3FTx-DIS4 from D. typus (0.21% and 0.12%),
and twoofwhichweremore abundant (4.36%and1.52%) and showed sim-
ilarity to 3FTx-DIS2 from D. typus and also Denmotoxin from Boiga
dendrophila [46,47]. We identiﬁed a single PLA2 contig that represented
7.56% of all toxin encoding genes, making it the third most abundant
toxin contig in the venom gland transcriptome. This toxin showed similar-
ity to the PLA2 IIE sub-class of phospholipases previously identiﬁed in the
venom of other colubroid snakes [48] and we did not recover any other
phospholipase genes that exhibited similarity to the IB or IIA classes of
PLA2s that are canonically associatedwith elapid andviperid snakevenoms,
respectively [49]. The remaining toxin types, CRISPs and SVSPs, were found
expressed at comparable levels (5.40% and 5.46%), with CRISPs encoded by
a single contig and the SVSPs by two; one of which was abundant (5.27%)
and the other a truncated variant with low-level expression (0.19%).e expression of toxin-encoding genes, non-toxin encoding genes and unidentiﬁed genes
oding genes present in the venom gland transcriptome. 3FTx, three-ﬁnger toxin; PLA2,
e; CTL, C-type lectin-like; KUN, Kunitz-type inhibitor; VEGF, vascular endothelial growth
Fig. 2. Bayesian inference phylogenetic analysis of D. typus snake venom metalloproteinase (SVMP) genes. D. typus genes are highlighted by red annotations and the origin of SVMPs
indicated by the arrow labelled venom. Black circles indicate Bayesian posterior probabilities (bpp) of 1.00 and grey circles bpp of ≥0.95.
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The venom proteome of adult D. typuswas characterised and quan-
tiﬁed using reverse-phase HPLC separation (Fig. 3, Supplementary Table
S1) and peptide-centric tandem mass spectrometry-based bottom-upFig. 3. Reverse-phaseHPLC separation and relativequantiﬁcation of the venomproteins of
D. typus. Fractionswere collectedmanually and analysed by SDS-PAGE (insets) under non-
reduced (upper panels) and reduced (lower panels) conditions. Protein bands were
excised and characterised by LC-nESI-CID-MS/MS (Supplementary Table S1). The pie
chart displays the relative abundance (in percentage of total venom proteins) of the
toxin families identiﬁed in the venom. DC, disintegrin-cysteine-rich domain; ni, not
identiﬁed; other acronyms as in the legend of Fig.1.venomics [37,38]. Nano-electrospray ionisation mass spectrometry
(nESI-MS/MS) identiﬁed proteins belonging to 7 different snake
venom protein families (Fig. 3, Supplementary Table S1), including a
3FTx (Dis-2 [ABU68481] [47], residues 22–94; Mave: 8437.7 Da); two
type IIE D-49 PLA2 molecules (AFH66958, residues 24–147, Mave:
13,642.1 Da; and an isoform of AFH66959, residues 24–147, Mave:
13,665.1 Da) [48]; two isoforms of CRISP molecules (Mave:
24,987.5 Da; residues 17–237 of Q2XXQ4 and Q2XXQ5 [50], with one
Mox); three SVSPs; one or two CTLs; a variety of SVMPs; and seven
Disintegrin-like/Cysteine-rich (DC) proteolytic fragments of PIII-
SVMPs. Reverse-phase chromatography, SDS-PAGE andMS/MS-derived
tryptic peptide approaches provided evidence for the translation of 19
SVMP-encoding transcripts, demonstrating that our transcriptome as-
sembly may have only resulted in a modest overestimation of SVMP
genes. D. typus SVMPs eluted in RP-HPLC fractions 4–14 and have mo-
lecular masses in the range of 21–97 kDa. On the other hand, the fact
that the same SVMP eluted in different chromatographic fractions and
display different molecular mass by SDS-PAGE analysis indicated the
existence of different proteoforms (“different molecular forms in
which the protein product of a single gene can be found”; e.g.
glycoforms) or closely related toxin isoforms (“forms of protein mole-
cules arising from the same gene”; i.e., full-length PIII-SVMPs and pro-
teolytically processed SVMPs that have released their C-terminal DC
domains) [51,52]. In this regard, ﬁve out of the seven DC domains iden-
tiﬁed in RP-HPLC fractions 1 and 2 (Fig. 3, Supplementary Table S1) also
formed part of full-length SVMPs, while the other two were only found
as processed DC domains and no evidence for the metalloproteinase
part of the protein was gathered. The proteomic data suggest the exis-
tence of 54 proteo/iso-SVMPs, 40 protein species of molecular masses
97–40 kDa and 14 SVMPs of molecular masses between 33 and
21 kDa. Collectively, these proteins account for 77.5% of the D. typus
venom proteome, with the majority (53% of the venom proteome) cor-
responding to the 52–66 kDa SVMPs (Fig. 3, Supplementary Table S1).
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VEGF andWAP transcripts in the boomslang venom proteome, the pro-
teomic- (Fig. 3) and transcriptomic-derived (Fig. 1) toxin compositions
agree remarkably well.3.3. Boomslang venom composition-activity correlations
The boomslang that fatally bit K.P. Schmidt was a young specimen,
and only one fang penetrated the skin to a depth of 3 mm. Unalarmed
by the bite, he decided to document the nature of his health in response
to a potential envenoming. K.P. Schmidt's meticulous “death notes”,
published by C.H. Pope in 1958 [1], represents a very unique and per-
sonal look at the effects of a boomslang bite while being objective
about it. Schmidt's diary stopped the following morning when he be-
lieved he was recovering. However, after noon he had difﬁculty breath-
ing and died soon after, shortly before 3:00 pm, due to respiratory
paralysis. The autopsy revealed that his difﬁculty in breathing was due
to bleeding into the lungs. The examination also showed hemorrhaging
in the renal pelvis and the small intestine which accounts for Schmidt's
documentation of blood in his urine and bowels. We now know that
several colubroid taxa can cause lethal or life threatening envenoming
in humans (see Table 4 in [53]), and the coagulopathic and
haemorrhagic character of boomslang venom has been demonstrated
in experimental animals [54]. Our present comprehensive report on
the venom proteome of the species that killed Schmidt gives us the op-
portunity of trying to correlate venom composition with the causes of
his fatal outcome. However, caution should be taken when assigning
bioactivities to colubroid toxins based on homology with toxins from
snakes of other families, as the biochemistry of colubroid toxins may
be very different from those of the well-studied front-fanged snakes.
Many non-front-fanged snake venoms exhibit modal or low lethal po-
tencies in themurinemodel but instead have high toxicity and potency
in some avian and lizardmodels [55,56]. Thus, members of the Elapidae
3FTx family exhibit a wide variety of pharmacological effects in labora-
tory animals (e.g. mice), including postsynaptic neurotoxicity, cytotox-
icity, cardiotoxicity, and anticoagulant, and antiplatelet activities [57,
58]. α-Colubritoxin, isolated from the Asian ratsnake Coelognathus
radiatus, represented the ﬁrst 3FTx reported from a non-front-fanged
snake venom [59]. This potent postsynaptic neurotoxin exhibits struc-
tural and functional homology to elapid nicotinic acetylcholine receptor
antagonistic 3FTXs [59]. However, other 3FTxs functionally
characterised from members of the subfamily Colubrinae, such as
denmotoxin (Boiga dendrophila) and irditoxin (B. irregularis), exhibit
taxon-speciﬁc activities [46,60]. The weak (b50%) amino acid sequence
identity of the D. typus 3FTx with elapid homologs, and the fact that de-
spite being an abundant venom toxin, the bite did not produce apparent
signs of neurotoxicity, suggests that this boomslang 3FTxmay represent
another taxon-speciﬁc toxin. By the same token, although their high
structural conservation and broad distribution among many front and
non-front-fanged snakes suggests a signiﬁcant biological role in
venom [12,41,61], the relevance of non-front-fanged snake venom
CRISPs in human envenomings is not yet clear. Patagonin, a CRISP isolat-
ed from the venom of P. patagoniensis, showed necrotic activity toward
murine gastrocnemius muscle when injected intramuscularly at doses
of 43 and 87 μg [62], possibly by binding to ion channels [63]. However,
at 20 μg, patagonin did not induce oedema or hemorrhage, and it had no
effect on the aggregation of human platelets or platelet-rich plasma (at
concentrations as high as 100 nM).
A number of snake venom toxins interact with components of the
human haemostatic system affecting the blood coagulation cascade
and platelet aggregation, including disintegrins, PLA2s, CTL-like mole-
cules, SVSPs, and SVMPs [64–66]. Except disintegrins, which are proteo-
lytically derived from PII-SVMPs and therefore only expressed in
venoms of Viperidae [67,68], the other toxin types targeting the
haemostatic system comprise N87% of the boomslang venom proteome(Fig. 3), which correlates well with the haemorrhagic pathology
observed in Schmidt's autopsy.
High levels of PLA2 activity have previously been reported inD. typus
venom [69]. The venoms of many terrestrial andmarine Australo-Papu-
an elapid snakes are also rich in D49-PLA2 toxins and cause a range of
actions including presynaptic neurotoxicity, myotoxicity, anticoagulant,
anti-platelet, hypotensive, haemorrhagic andmyonecrotic activities [70,
71]. Relevant to this discussion is the recent report that P. papuanus
venom induced lethality, intravascular hemolysis, pulmonary conges-
tion and edema, and anticoagulation after intravenous injection in
mice, and these effects were mainly due to the action of PLA2s [72].
The CTLs identiﬁed in the boomslang venom show 60% sequence
identity to a vast number of snake venom CTLs, particularly contigs
T1304, T3784 and T1088which exhibit 87%, 84% and 94% amino acid se-
quence identity to B. irregularis CTL-6 [JAS04587] and CTL-5 [JAS04588]
[73], and lectoxin-Thr1 [A7X3Z0] from T. jacksonii [47] respectively.
CTLs inhibit or activate platelets by binding to various receptors [74].
Activation represents an efﬁcient way to reduce platelet function be-
cause activated platelets are removed from the circulation producing
thrombocytopenia. The mechanisms by which D. typus CTLs affect he-
mostasis has not yet been studied.
Serine proteases (SVSPs), include a variety of venomenzymeswhich
interfere with vertebrate hemostasis and have previously been docu-
mented from colubroid venoms. In addition to D. typus, bites from sev-
eral colubroids have resulted in prolonged clotting times (Rhabdophis
tigrinus), prolonged deﬁbrination (R. subminiatus), prothrombin activa-
tion (Thelotornis capensis; R. tigrinus; R. subminiatus) and other distur-
bances of hemostasis [12]. Bites from these species cause consumptive
coagulopathy and haemorrhagic diathesis, complicated in some cases
by acute kidney injury, and are designated “Hazard Level 1” [53].
Fibrin(ogen)olytic serine proteases have isolated from the venom of
Philodryas olfersii [75]. D. typus venom serine proteinases exhibit 75–
78% amino acid sequence identity with a number of proteolytic en-
zymes from colubroid (P. olfersii Q09GK1 [76]) and elapid venoms, in-
cluding the ﬁbrin(ogen)olytic enzymes Q5MCS0 (Hydrophis
hardwickii) [77] and A8QL56 (Ophiophagus hannah) [78].
For most colubroid species, especially in the subfamily Dipsadinae,
snake venom metalloproteinases (SVMPs) are dominant components
in transcriptomes and proteomes [41]. Our results here demonstrate
that the vastmajority of toxin genes expressed in the venomgland tran-
scriptome (~75%) and toxin proteins detected in secreted venom
(~78%) are SVMPs. All sequences described in non-front-fanged snakes
to date belong to (or are derived from) the P-III class of SVMPs [79] and
weﬁnd the samewith the boomslang.D. typus PIII-SVMPs show66–69%
identity to Boiga irregularis, Hypsiglena sp. JMG-2014, Phalotris mertensi
and Philodryas olfersii SVMPs. They also have signiﬁcant homology (50–
65%) to elapid and viperid PIII-SVMP, including 61–63% identity to Fac-
tor X activators fromDaboia russelii russelii (ADJ67475) andMacrovipera
lebetina (Q7T046).
A 67 kDa prothrombin activator (“coagulant principle”,
“procoagulant”) from D. typus venom has been partially characterised
[80]. This protein is likely the SVMP termed dispholysin A, which was
previously reported to cross-react with polyclonal antibodies to the
Bothrops jararaca venommetalloprotease jararhagin [22]. A central fea-
ture of the clinical pathology produced by envenomations by
procoagulant SVMPs is a DIC-like (disseminated intravascular coagula-
tion-like) syndrome [65]. This clinical pathology is characterised by de-
pletion of ﬁbrinogen from the blood as a result of prothrombin
activation, resulting in a net effect of incoagulable blood. About 50% of
all D. typus SVMPs have the same molecular mass as dispholysin A,
and it is therefore tempting to speculate that this procoagulant SVMP
may have been at least partially responsible for potentiating the bleed-
ing pathology observed in the case of K.P. Schmidt. Boomslang venom
also contains a number of other PIII-SVMPs, and it seems reasonable
to state that it is likely some of these are haemorrhagic, considering
many PIII-SVMPs are potently haemorrhagic [81,82]. The combined
Fig. 4. Immunoafﬁnity antivenomics analysis of D. typus venom against CroFab™
antivenom. Panel a, reference RP-HPLC separation of proteins of D. typus venom. Protein
classes identiﬁed in the different chromatographic fractions are highlighted. Panels b
and c display, respectively, reverse-phase separations of the immunocaptured and the
non-bound column fractions recovered after incubating 100 μg of venom with 300 μL of
Sepharose-immobilised (5.1 mg) CroFab™ antivenom. Panels d and e show,
respectively, reverse-phase HPLC separations of the venom components recovered,
respectively, in the bound and non-bound fractions of a mock Sepharose 4 Fast Flow
matrix column (matrix control). Column eluates were monitored at 215 nm and
quantiﬁed by comparing the areas of homologous peaks in the two fractions. Numbers
indicate the percentage of venom component in the chromatographic fraction.
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platelets (from ongoing activation of coagulation) and the action of
haemorrhagic SVMPs may have resulted in widespread clotting and
bleeding. Unveiling the functional features of the full complement of
boomslang SVMPs deserves a detailed toxicovenomics investigation
[83,84].
3.4. Antivenomic assessment of the immunoreactivity of CroFab™ towards
boomslang venom proteins
We tested the ability of a commercially available N. American anti-
venom (CroFab™) to immunocapture boomslang venom proteins
using an antivenomics approach. Whilst this antivenom was not avail-
able at the time of K.P. Schmidt's death, having since superseded the his-
torical Wyeth-Ayerst Laboratories Antivenin (Crotalidae) Polyvalent
(ACP) that was available at that time, a number of the venoms used
for producing the two antivenoms are shared (e.g. C. adamanteus, C.
atrox). Perhaps surprisingly, when considering the degree of taxonomic
separation between colubroid (i.e. D. typus) and viperid snakes (i.e. C.
adamanteus and C. atrox), CroFab™ showed cross-immunoreactivity to-
wards most boomslang venom proteins, albeit with varying degrees of
afﬁnity (Fig. 4). CRISP and the major SVMP peaks (11–14, Fig. 3) were
efﬁciently (51–64%) immunoretained, while the PLA2 molecule, SVSPs,
and SVMPs eluting in peak 11 were immunoretained to a lesser (35%)
extent (compare panels b and c of Fig. 4). On the other hand, the small
amounts (8%) of immunoretained 3FTx (Fig. 4, panel b)were not signif-
icantly different from those of the same chromatographic fractions non-
speciﬁcally retained in the control column (mock chromatographic
matrix) (Fig. 4, panel d). Although a correlation between the level of
immune recognition gathered from antivenomics with the in vivo pre-
clincial neutralization capacity of an antivenom is not straightforward,
since both experiments involve radically different protocols, our previ-
ous experience shows that even a moderate immunocapturing capabil-
ity of ~20%–25% can correlatewith a good outcome in pre-clinical in vivo
neutralization tests [83].
4. Concluding remarks
Prof. K.P. Schmidt succumbed to thebite of a snake considered by the
herpetologists of the time as harmless to humans. Since then, only a
handful of studies on the biological activities of the venom of this
colubroid have been reported [7,14–16,21,22], and only a few cases of
human and veterinary envenomings byD. typus have been documented
[8,9,15–17,84–91]. The present work is the ﬁrst to address a compre-
hensive proteomic characterization of D. typus venom, allowing us to
correlate its toxin composition with the toxic activities of this venom.
At the time the unfortunate accident occurred no speciﬁc antivenom
against boomslang venomwas available. However, awhole IgG antiven-
om, Antivenin (Crotalidae) Polyvalent (ACP), was introduced in USA by
Wyeth-Ayerst Laboratories in 1954 [92]. The ACP antivenomwas gener-
ated in horses against a mixture of venoms from the Eastern diamond-
back (C. adamanteus), Western diamondback (C. atrox) and South
American (C. durissus terriﬁcus) rattlesnakes, and the fer-de-lance
(Bothrops asper), and has been an important part of snakebite therapy
for 35 years, particularly for the life-threatening or coagulopathic man-
ifestations of crotaline snakebite in USA [93]. As mentioned earlier, the
Wyeth-Ayerst antivenom has since been replaced by CroFab™
[Crotalidae Polyvalent Immune Fab (ovine)], a preparation of ovine
Fab (monovalent) immunoglobulin fragments obtained from the
blood of healthy sheep immunized with one of the following North
American snake venoms: C. atrox, C. adamanteus, C. scutulatus type A
and A. piscivorus. Venoms of C. adamanteus, C. atrox, B. asper, and A.
piscivorus are characterised by a high content of haemorrhagic SVMPs
[94–96]. Full-length amino acid sequences of boomslang venom gland
SVMP-encoding transcripts exhibit ~61% identity with a number of
PIII-SVMPs from venoms of Agkistrodon and Crotalus species, suggesting
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immunoreactivity against the boomslang SVMPs. This assumption is
supported by the well documented immunoreactivity among SVMPs
from phylogenetically distant snakes [97,98], including the previously
reported cross-reaction of D. typus SVMP dispholysin A with polyclonal
antibodies generated against the SVMP jararhagin from B. jararaca [22].
Moreover, the efﬁcient immunodepletion of some boomslang SVMPs in
our CroFab™ afﬁnity column (Fig. 4) further underpins this hypothesis.
So, what killed KP Schmidt? The boomslang is a timid snake, and
bites generally occur only when people attempt to handle, catch or kill
the animal, and thus K.P. Schmidt's fatal outcome was presumably due
to an accumulation of unfortunate circumstances. On the one hand,
the carefree handling of the snake (“I took it fromDr. Robert Ingerwithout
thinking of any precaution, and it promptly bit me on the ﬂeshy lateral as-
pect of the ﬁrst joint of the left thumb. The mouth was widely opened and
the bite was made with the rear fangs only, only the right fang entering
to its full length of about 3 mm”), on the other the false prevailing belief
in the scientiﬁc, medical and popular literature of that time that consid-
ered colubroids as harmless snakes and consequently that bites by rear-
fanged snakes did not pose medical risks to humans, may have contrib-
uted to K.P. Schmidt refusing to receivemedical attention. And, if he had
soughtmedical treatment, would hehad been treatedwith the available
anti-Crotalidae polyvalent antivenom? There was no clinical studies
that hinted to the possible effectiveness of ACP antivenom in a
boomslang envenoming, and even to this day, we are unaware of any
reports of viper antivenoms being demonstrated to be pre-clinically or
clinically efﬁcacious for treating systemic envenoming caused by
colubroid snakes.
Advancements in venomic analysis have resulted in the ability to
generate comprehensive proﬁles of a large number of snake venoms
[99], including a growing number of rear-fanged snakes [41,42]. Bio-
chemical and pharmacological studies have also deepened our knowl-
edge about rear-fanged snake venoms, and revealed that a number of
species (D. typus, Thelotornis capensis, Rhabdophis tigrinus, R.
subminiatus, Balanophis ceylonensis, Philodryas olfersii, and Tachymenis
peruviana) are able to deliver lethal quantities of venoms and cause
human fatalities [10,12,53,100–107]. Increasing awareness of life-
threatening envenomings from rear-fanged snake bites should lead to
an increased interest in research focused on these venoms, which in
turn should contribute to prevent fatal human accidents, such as that
unfortunately suffered by Karl Patterson Schmidt.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbagen.2017.01.020.
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